4.4 Article

Safety evaluation of the food enzyme endo-polygalacturonase from the non-genetically modified Aspergillus tubingensis strain MUCL 55013

期刊

EFSA JOURNAL
卷 21, 期 11, 页码 -

出版社

WILEY
DOI: 10.2903/j.efsa.2023.8397

关键词

(1 -> 4)-alpha-d-galacturonan glycanohydrolase; Aspergillus tubingensis; EC 3.2.1.15; endo-polygalacturonase; food enzyme; non-genetically modified microorganism

向作者/读者索取更多资源

The food enzyme endo-polygalacturonase produced with non-genetically modified Aspergillus tubingensis strain MUCL 55013 is considered safe for use in various food manufacturing processes. The dietary exposure to this enzyme was estimated to be up to 7.834 mg TOS/kg bw per day. Genotoxicity tests and repeated dose toxicity study in rats showed no safety concerns. While there is a risk of allergic reactions, it is not higher than the risk associated with consuming papaya.
The food enzyme endo-polygalacturonase ((1 -> 4)-alpha-D-galacturonan glycanohydrolase (endo-cleaving); EC 3.2.1.15)) is produced with the non-genetically modified Aspergillus tubingensis strain MUCL 55013 by Soufflet Biotechnologies. The food enzyme is free from viable cells of the production organism. It is intended to be used in 10 food manufacturing processes: processing of fruits and vegetables for the production of juices, other fruit and vegetable products, wine, distilled spirits from wine, alcoholic beverages other than grape wine; processing of plant-derived products for the production of refined and unrefined sugar, edible oils from plants, green coffee beans by demucilation, coffee extracts and tea and other herbal and fruit infusions. Since residual amounts of total organic solids (TOS) are removed in three processes, dietary exposure was calculated only for the remaining seven food manufacturing processes. Exposure was estimated to be up to 7.834 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 2,097 mg TOS/kg bw per day, the highest dose tested, resulting in a margin of exposure of at least 268. A search for the similarity of the amino acid sequence of the food enzyme to known allergens found 14 matches, one of which was to a food allergen. The Panel considered that the risk of allergic reactions upon dietary exposure to this food enzyme cannot be excluded, in particular for individuals sensitised to papaya, but that the risk will not exceed that of consumption of papaya. In addition, oral allergy reactions cannot be excluded in pollen-sensitised individuals. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据